Valsartan
ENTRESTO is a combination of sacubitril, a neprilisin inhibitor, and valsartan, an angiotensin II receptor blocker, and is indicated: to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure.
United States
$10
per month
India
$1
per month
You save
−94%save $10/mo · 94% cheaper
4.7M US scripts/yr$44.9M potential annual savings$47.7M US spend/yr
Drag to rotate · 3D structureC24H29N5O3
SMILES: CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O
Compare the price
US price$10per month
India price$1per month
You save$1094% less
Based on 30 units per month. US $0.34 vs India $0.02 per unit.
Total over 1 periodSave $10$10 → $1
The bigger picture
Valsartan is filled about 4.7M times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$47.7M
If sourced from India
$2.8M
Potential annual savings
$44.9M
−94%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.